THE EFFECT OF FAMILY MOTIVATIONAL INTERVENTION ON MEDICATION ADHERENCE OF PERSONS WITH SCHIZOPHRENIA IN COMMUNITY
Article Sidebar
Main Article Content
Abstract
Objectives: To examine the effect of Family Motivational Intervention (FMI) on medication adherence of persons with schizophrenia in community.
Methods: The research was a quasi experimental design. The sample consisted of 40 families of persons with schizophrenia in com munity who met the inclusion criteria and received services at the outpatient department in Samchuk Hospital. The subjects were matched pair by age and medication adherence behavior and then randomly assigned into experimental group and control group, 20 families in each group. The experimental group received the FMI and the control group received regular nursing care. Research instruments were: 1) the FMI, 2) The Medication Adherence Scale, 3) The Stage of Change Readiness and Treatment Eagerness Scale, 4) The Competency of Motivation Interviewing Scale, and 5) The Competency of Motivation Interviewing Observational Scale. All instruments were verified for content validity by 5 professional experts. The reliability of the 2nd, 3rd and 4th instrument was reported by Cronbach’s alpha as of .83, .82 and .81 and the 5th instrument was reported by Pearson’s correlation as of .99. The t-test was used for data analysis. Results: 1) Medication adherence of persons with schizophrenia in community who received the FMI was significantly higher than that before (p < .05). 2) After the experiment, medication adherence of persons with schizophrenia in community who received the FMI was significantly higher than that of those who received the regular nursing care (p < .05).
Article Details
บทความที่ได้รับการตีพิมพ์แล้ว เป็นลิขสิทธิ์ของสมาคมพยาบาลจิตเวชแห่งประเทศไทย
References
พิชัย แสงชาญชัย, ดรุณี ภู่ขาว, สังวร สมบัติใหม่, ณัฐนาฏ สระอุบล, สายรัตน์ นกน้อย, และ เพ็ญพักตร์ อุทิศ. (2553). การให้คำปรึกษาและการบำบัดเพื่อเสริมสร้างแรงจูงใจในผู้ป่วยที่มีปัญหาการดื่มสุรา. เชียงใหม่: วนิดาการพิมพ์.
เพชรี คันธสายบัว. (2544). การวิเคราะห์ตัวแปรจำแนกกลุ่มผู้ป่วยจิตเภทที่ป่วยซ้ำและไม่ป่วยซ้ำ. วิทยานิพนธ์ปริญญามหาบัณฑิต, สาขาการพยาบาลสุขภาพจิตและจิตเวช คณะ พยาบาลศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย.
มาโนช หล่อตระกูล และปราโมทย์ สุคนิชย์. (2552). จิตเวชศาสตร์รามาธิบดี (พิมพ์ครั้งที่ 2). กรุงเทพมหานคร: บียอนด์เอ็นเตอร์ไพรซ์.
สมภพ เรืองตระกูล. (2553). ตำราจิตเวชศาสตร์ (พิมพ์ครั้งที่ 7). กรุงเทพมหานคร: เรือนแก้ว การพิมพ์.
สรินทร เชี่ยวโสธร. (2545). ผลของการเสริมสร้างพลังอำนาจในผู้ป่วยจิตเภทต่อพฤติกรรมการใช้ยาตามเกณฑ์การรักษา. ปริญญามหาบัณฑิต. สาขาการพยาบาลสุขภาพจิตและจิตเวช คณะพยาบาลศาสตร์ จุฬาลงกรณ์ มหาวิทยาลัย.
Agarwal, M. R., Sharma, V. K., KV, K. K., & Lowe, D. (1998). Non-compliance with treatment in patients suffering from schizophrenia: A study to evaluate possible contributing factors. International Journal of Social Psychiatry, 44(2), 92-106.
Burn, N., & Grove, S. K. (2009). The Practice of Nursing Research: Conduct, Critique and Utilization (6th ed.). St. Louise: W.B. Saunders. Cullum, N.
Cain, C. I., & Wick, M. N. (2002). Care giving attitudes as correlates of burden in family caregiver coping with chronic obstructive pulmonary disease. Journal of Family Nursing, 6, 46-47.
Chien, W. T. (2008). Effectiveness of Psychoedu¬cation and Mutual Support Group Program for Family Caregiver of Chinese People with Schizophrenia. The open nursing Journal, 2, 28-39.
Drymaski, W. M., & Campbell, T. C. (2009). A review of motivational interviewing to enhance adherence to antipsychotic medication in patients with schizophrenia: Evidence and recommendations. Journal of Mental Health, 8, 6-15.
Faerden, A., Finset, A., Friis, S., Agartz, I., Barrett, E.A., Nesvag, R., et al. (2010). Apathy in first episode psychosis patients: one year follow up. Schizophrenia Research, 116, 20-26.
Farragher, B., (1999). Treatment compliance in the mental health service. Irish Medication Journal, 92(6), 1-3.
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., et al. (2004). Adherence to treatment with antipsychotic medication and health care cost among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692-699.
Horwath, E., & Cournos, F. (1999). Psychiatry. Philadelphia: W.B. Saunders.
Kane, J. M. (2007). Treatment strategies to prevent relapse and encourage remission. The Journal of Clinical Psychiatry, 68, 27-30.
Kazadi, N. J. B., Moosa, M. Y. H., & Jeenah, F. Y. (2008). Factors associated with relapse in Schizophrenia. South African Joural of Psychiatry, 4(2), 52-62.
Kumar, S., & Sedgwick, P. (2001). Non-compliance to psychotropic medication in Eastern India: Clients’ perspective. Journal of Mental Health, 10(3), 279-284.
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63, 892-909.
Maneesakorn, S., Robso, D., Gourna, K., & Gray, A. (2007). An RCT of adherence therapy for people with schizophrenia in Chiang Mai Thailand. Journal of clinical Nurse, 16, 1302-1312.
Miller, W. R., & Rollnick, S. (2002). Motivational interview in: preparing people to change addictive behavior. New York: Guilford Press.
Miller, W. R., & Tonigan, J. S. (1996). Assessing drinkers’ motivation for change: The stage of change readiness and treatment eagerness scale (SOCRATES). Psychology of Addictive Behavior, 10, 81-89.
Nakonezny, P. A., & Byerly, M. J. (2006). Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first vs second generation antipsychotics. Schizophrenia Research, 82, 107-114.
Novick, D., Haro, J. M., Duarez, D., Perez, V., Dittmann, R.W., & Haddad, P. M. (2010). Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research, 173(2), 109-113.
Smeerdijk, A. M., Keet, R., Dekker, N., van Raaij, B., Krikke, M., Koeter, M., et al. (2011). Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial. Psychology Medicine, 42(8), 1627-1636.
Smeerdijk, A. M., Keet, R., de Haan, L., Barrowclough, C., Linszen, D., & Schippers, G. (2014). Feasibility of teaching motivational interviewing to parent of young adults with recent-onset schizophrenia and co-occurring cannabis use. Journal of Substance Abuse Treatment, 46, 340-345.
Smeerdijk, A. M., Linszae, D., Kuipers, T., & Keet, R. (2009). Family Motivational Intervention in Early Psychosis and Cannabis Misuse. In Lobban, F., & Barrowclough, C. (Eds.). A casebook of family interventions for psychosis. Chi Chester: John Wiley & Sons.
Spirito, A., Sindelar-Manning, H., Colby, S. M., Barnett, N. P., Lewander, W., Rohsenow, D. J., et al. (2011). Individual and family motivational interventions for alcohol positive adolescents treated in an emergency department. Archives of Pediatrics and Adolescent Medicine journal, 165(3), 269-274.
Wagner, C. C., & Ingersoll, K. S. (2013). Motivational Interviewing in Groups. New York: Guilford Press.
Wu, E. Q., Birnbaum, H. G., Shi, L., Ball, D. E., Kessler, R. C., & Moulis, M. (2005). The economic burden of schizophrenia in the United States in 2002. Journal of Clinical Psychiatry, 66, 1122-1129.
